Brooks Moore & Associates’s Corteva CTVA Stock Holding History

Brooks Moore & Associates’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-18,919	Closed	-$559K	–	96
2019 Q2	$559K	Buy	+18,919	New	+$509K	0.48%	67

Other funds holding CTVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brooks Moore & Associates's CTVA Position: Q3 2019 in Review

Brooks Moore & Associates sold out of Corteva (CTVA) in Q3 2019, closing a stake of 18,919 shares — an estimated $559K sold.

Brooks Moore & Associates first reported a position in CTVA in Q2 2019 and held it in 1 quarter. The position peaked at $559K in Q2 2019. 983 funds tracked by Wall St. Rank hold CTVA as of Q3 2019.

Brooks Moore & Associates reported no remaining Corteva position as of Q3 2019 after selling out during the quarter.
Brooks Moore & Associates sold 18,919 Corteva shares in Q3 2019, an estimated $559K.
Brooks Moore & Associates first reported a position in Corteva in Q2 2019 and held it in 1 quarter.
Brooks Moore & Associates's Corteva position peaked at $559K in Q2 2019.
983 funds tracked by Wall St. Rank held Corteva as of Q3 2019.

Based on Brooks Moore & Associates's 13F filing for Q3 2019, filed 25 Oct 2019.